(Q36309632)

13 August 2017

1 reference

title

Medications associated with weight gain (English)

1 reference

13 August 2017

1 reference

Margaret Malone

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

8 November 2005

1 reference

Annals of Pharmacotherapy

13 August 2017

published in

1 reference

13 August 2017

volume

39

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

2046-2055

1 reference

Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians

13 August 2017

cites work

1 reference

The impact of weight gain on quality of life among persons with schizophrenia.

21 January 2018

1 reference

Patient attitudes toward weight gain with medications

21 January 2018

1 reference

Intentional and unintentional nonadherence to antihypertensive medication

21 January 2018

1 reference

Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes

21 January 2018

1 reference

Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment.

21 January 2018

1 reference

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

21 January 2018

1 reference

Weight gain and new onset diabetes associated with olanzapine and risperidone

21 January 2018

1 reference

Weight gain during long-term treatment with olanzapine: a case series

21 January 2018

1 reference

Risk of weight gain associated with antipsychotic treatment: results from the Canadian National Outcomes Measurement Study in Schizophrenia

21 January 2018

1 reference

Current options in the management of olanzapine-associated weight gain

21 January 2018

1 reference

The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study

21 January 2018

1 reference

Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial

21 January 2018

1 reference

Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study

21 January 2018

1 reference

Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain

21 January 2018

1 reference

Nizatidine for the treatment of patients with quetiapine-induced weight gain

21 January 2018

1 reference

Effect of amantadine on weight gain during olanzapine treatment

21 January 2018

1 reference

Amantadine for weight gain associated with olanzapine treatment

21 January 2018

1 reference

Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study

21 January 2018

1 reference

Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition

21 January 2018

1 reference

Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients

21 January 2018

1 reference

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

21 January 2018

1 reference

A program for managing weight gain associated with atypical antipsychotics.

21 January 2018

1 reference

Weight gain and serum leptin levels in patients on lithium treatment

21 January 2018

1 reference

Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

21 January 2018

1 reference

Weight Gain During Long-Term Treatment of Obsessive-Compulsive Disorder

21 January 2018

1 reference

Effects of Nefazodone on Body Weight

21 January 2018

1 reference

A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.

21 January 2018

1 reference

Quetiapine-induced weight gain and escitalopram

21 January 2018

1 reference

Bodyweight gain and anticonvulsants: a comparative review

21 January 2018

1 reference

Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy

21 January 2018

1 reference

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

21 January 2018

1 reference

Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril).

21 January 2018

1 reference

Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.

21 January 2018

1 reference

Changes in body weight with chronic, high-dose gabapentin therapy

21 January 2018

1 reference

21 January 2018

Oral Antidiabetic Agents

1 reference

Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

21 January 2018

1 reference

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

21 January 2018

1 reference

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

21 January 2018

1 reference

Improved glycemic control without weight gain using triple therapy in type 2 diabetes

21 January 2018

1 reference

21 January 2018

1 reference

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

21 January 2018

1 reference

Glitazones, glycemia, and global health status

21 January 2018

1 reference

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes

21 January 2018

1 reference

Are the metabolic effects of rosiglitazone influenced by baseline glycaemic control?

21 January 2018

1 reference

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

21 January 2018

1 reference

Efficacy of Sulfonylureas with Insulin in Type 2 Diabetes Mellitus

21 January 2018

1 reference

Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy

21 January 2018

1 reference

Repaglinide versus nateglinide monotherapy: a randomized, multicenter study

21 January 2018

1 reference

New drugs for management of diabetes: insulin analogues, inhaled insulin, pramlintide, and novel peptides

21 January 2018

1 reference

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

21 January 2018

1 reference

Long term propranolol treatment and changes in body weight after myocardial infarction

21 January 2018

1 reference

Weight gain induced by long-term propranolol treatment

21 January 2018

1 reference

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis

21 January 2018

1 reference

Do beta-blockers put on weight?

21 January 2018

1 reference

Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents

21 January 2018

1 reference

Weight change with oral contraceptive use and during the menstrual cycle. Results of daily measurements

21 January 2018

1 reference

Effects of low-dose OCs on weight in women with Central European nutritional habits and lifestyle

21 January 2018

1 reference

A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet (gestodene75/EE20) on body fat.

21 January 2018

1 reference

A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives

21 January 2018

1 reference

Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years

21 January 2018

1 reference

Depo-provera associated with weight gain in Navajo women

21 January 2018

1 reference

Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G333

1 reference

13 August 2017

1 reference